GlassScriptPhysician profile
Roya Rahimi
NPI 1760880470
$2,615.18
in general payments reported to CMS, 2019-2025
36 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what 90% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $639 · 2022: $371 · 2023: $443 · 2024: $161 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,605.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $307.50 | 2021-2025 | Tymlos |
| Ferring Pharmaceuticals INC. | $296.65 | 2021-2025 | Euflexxa |
| Horizon Therapeutics Plc | $188.64 | 2021-2022 | |
| Miach Orthopaedics, INC. | $168.46 | 2023 | |
| Amgen INC. | $151.50 | 2021-2025 | Evenity, Prolia |
| Zimmer Biomet Holdings, INC. | $140.41 | 2025 | Totalshield, Tapestry |
| Smith+Nephew, INC. | $136.55 | 2025 | Pico 14 |
| Globus Medical, INC. | $131.34 | 2025 | Senza |
| Pacira Pharmaceuticals Incorporated | $120.29 | 2025 | Exparel |
| Pacira Therapeutics, INC. | $113.66 | 2021 | |
| Fidia Pharma USA INC. | $103.92 | 2021-2025 | Hymovis |
| Stryker Corporation | $73.45 | 2024 | Mako |
| Ucb, INC. | $62.23 | 2021-2025 | Cimzia, Bimzelx |
| Heron Therapeutics, INC. | $53.42 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $48.33 | 2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $43.12 | 2023-2025 | |
| Boston Scientific Corporation | $42.12 | 2021 | |
| Ethicon US, LLC | $38.46 | 2022 | |
| Bioventus LLC | $37.26 | 2023-2025 | Xcell, Bonescalpel |
| Linkbio Corp | $37.06 | 2025 | |
| Dynasplint Systems INC. | $33.50 | 2023 | Dynasplint |
| Biotronik Nro, INC. | $33.46 | 2025 | |
| Avanos Medical | $26.92 | 2023 | Trivisc Sodium Hyaluronate |
| Medtronic, INC. | $25.97 | 2025 | Inceptiv |
| Si-Bone, INC. | $23.43 | 2021 | |
| Depuy Synthes Sales INC. | $22.03 | 2025 | Orthovisc, Monovisc |
| Alvogen INC | $17.70 | 2023 | Teriparatide |
| Molnlycke Health Care US, LLC | $16.59 | 2023 | Mepilex Border Post-Op Ag, Mepilex Border Post-Op |
| Kiniksa Pharmaceuticals International, Plc | $16.18 | 2024 | Arcalyst |
| Janssen Biotech, INC. | $16.16 | 2025 | Tremfya |
| Kyowa Kirin, INC. | $15.95 | 2023 | Crysvita |
| Electronic Waveform Lab, INC. | $15.33 | 2025 | |
| Sanofi-Aventis U.S. LLC | $15.04 | 2023 | |
| Endo Pharmaceuticals INC. | $14.57 | 2022 | |
| Abbvie INC. | $14.50 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.48 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roya Rahimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.